title: Emerging risk factors and early atherosclerosis indices in subjects with impaired glucose tolerance.
abstract: OBJECTIVE
  To evaluate the response to an oral lipid overload, inflammatory markers and carotid intima-media thickness in subjects with impaired glucose tolerance.
  
  
  METHODS
  54 subjects, both sexes, 58 y-old average were submitted to 1) Clinical evaluation 2) Glucose tolerance test with 75 g glucose; classified as normal (2 h plasma glucose<140 mg/dl, n=37) or IGT (2 h G 140-200 mg/dl, n=17), 3) 12 h fasting sample (plasma glucose, lipids, C-reactive protein, fibrinogen and HOMA-IR calculation); 4 and 6 h after the oral lipid overload (1000 kcal, lipids 65 g) glycemia, fibrinogen and triglycerides were reevaluated. Intima-media thickness was calculated by the average of 6 measurements (3 highest of each carotid) evaluated by ultrasonography (7 MHZ transducer).
  
  
  RESULTS
  The IGT group had higher (P<0.001) fasting plasma glucose (89.4 +/- 13 vs 104.4 +/- 8 mg/dl), HOMA-IR (1.69 +/- 1.2 vs 2.93 +/- 2.2) and waist (91 +/- 14 vs 101 +/- 9 cm), similar fasting lipids, intima-media thickness (P=0.58) and post-oral lipid overload triglycerides (P=0.74), but higher fibrinogen (284.3 +/- 6 and 305 +/- 10 mg/dl, P=0.05) and C-reactive protein (2.11 +/- 0.33 and 4.19 +/- 0.65 mg/l, P=0.003). C-reactive protein was positively correlated with HOMA-IR (r=0.45, P=0.001), fasting plasma glucose (r=0.43, P=0.002) and waist (r=0.45, P=0.0006), but not with postprandial lipids.
  
  
  CONCLUSIONS
  A higher C-reactive protein in IGT, and its positive correlation with insulin resistance indices, but not with postprandial lipaemia, suggests that the clustering of these factors, characteristic of the metabolic syndrome, occurs earlier than postprandial lipid abnormalities.
authors.affiliation: Post-Graduate Program in Health Sciences, Instituto de Cardiologia do Rio Grande do Sul/Cardiologia da Fundação, Unidade de Pesquisa, Dra. Av. Princesa Isabel 370, Santana, Porto Alegre CEP 90.620-001, Brazil. editoricao-pc@cardiologia.org.br
authors.forename: B D
authors.initials: BD
authors.lastname: Schaan
authors.forename: V L
authors.initials: VL
authors.lastname: Portal
authors.forename: M T O
authors.initials: MT
authors.lastname: de Ugarte
authors.forename: A A
authors.initials: AA
authors.lastname: Dias
authors.forename: D M
authors.initials: DM
authors.lastname: Hatem
mesh_terms: D050197:Atherosclerosis / Q000453:epidemiology*; D001786:Blood Glucose / Q000378:metabolism; D049628:Body Size; D002097:C-Reactive Protein / Q000378:metabolism; D002339:Carotid Arteries / Q000473:pathology; D005215:Fasting; D005260:Female; D018149:Glucose Intolerance / Q000097:blood* / Q000503:physiopathology*; D005951:Glucose Tolerance Test; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D017539:Tunica Intima / Q000473:pathology; D017540:Tunica Media / Q000473:pathology
chemical_list: D001786:Blood Glucose; D008055:Lipids; D002097:C-Reactive Protein